Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors
2023 · Science · 163 citations
https://doi.org/10.1126/science.abo7201
A
André S. Godoy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
1.5K
Citations
21
h-index
30
i10-index
André S. Godoy is an academic researcher from Universidade Federal de Santa Maria. The author has contributed to research in topics: Mosquito-borne diseases and control & SARS-CoV-2 and COVID-19 Research & Computational Drug Discovery Methods. The author has an h-index of 21, co-authored 88 publications.
ORCID: 0000-0002-0613-9164Papers by this author
worksStructural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease
2023 · Journal of Biological Chemistry · 112 citations
https://doi.org/10.1016/j.jbc.2023.103004
Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors
2021 · Molecules · 35 citations
https://doi.org/10.3390/molecules26164896
An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition
2023 · Nature Communications · 25 citations
https://doi.org/10.1038/s41467-023-37035-5
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitors
2025 · Nature Communications · 6 citations
https://doi.org/10.1038/s41467-025-63602-z
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
2025 · Research Square · 1 citations
https://doi.org/10.21203/rs.3.rs-5876218/v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat